AbbVie (ABBV)

104.20 +0.24 (0.23%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (2/9/21 *Est.)
- M&A (11/30/-1 *Est)
- M&A (12/31/16 *Est)
- Conference (12/2/2020)

Latest Headlines

Form 4 AbbVie Inc. For: Nov 20 Filed by: Gosebruch Henry O November 24, 2020 5:35 PM - SEC Filing AbbVie to Present at the Evercore ISI Conference and Piper Sandler Healthcare Conference November 24, 2020 8:00 AM - PR NewsWire Form CERT AbbVie Inc. November 20, 2020 4:21 PM - SEC Filing Form 8-A12B AbbVie Inc. November 20, 2020 4:06 PM - SEC Filing Form 3 AbbVie Inc. For: Nov 09 Filed by: Sorg Elaine K. November 19, 2020 4:49 PM - SEC Filing Form 8-K AbbVie Inc. For: Nov 18 November 18, 2020 5:17 PM - SEC Filing Form 4 AbbVie Inc. For: Nov 16 Filed by: ALBAN CARLOS November 18, 2020 5:05 PM - SEC Filing AbbVie Announces Expiration and Final Results of Registered Exchange Offers November 18, 2020 5:00 PM - PR NewsWire BMO Capital Starts Abbvie (ABBV) at Outperform; Well-Positioned to Manage Humira's LOE November 18, 2020 4:01 AM - StreetInsider Berkshire's bet a bright spot in gloomy year for Big Pharma stocks November 18, 2020 1:03 AM - StreetInsider Buffett's Berkshire Hathaway Enters AbbVie (ABBV), Bristol-Myers (BMY), Merck (MRK), Pfizer (PFE), T-Mobile (TMUS) - 13F November 16, 2020 4:10 PM - StreetInsider Berkshire Hathaway shows a new stake in AbbVie (ABBV) November 16, 2020 4:04 PM - StreetInsider Allergan Aesthetics Celebrates Second Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day November 16, 2020 8:00 AM - PR NewsWire Form 4 AbbVie Inc. For: Nov 10 Filed by: SALEKI-GERHARDT AZITA November 12, 2020 5:57 PM - SEC Filing Form 4/A AbbVie Inc. For: Nov 04 Filed by: SALEKI-GERHARDT AZITA November 12, 2020 5:56 PM - SEC Filing Form 4 AbbVie Inc. For: Nov 09 Filed by: GONZALEZ RICHARD A November 12, 2020 5:55 PM - SEC Filing Form 8-K AbbVie Inc. For: Nov 09 November 12, 2020 10:06 AM - SEC Filing AbbVie to Present at the Wolfe Research Healthcare Conference November 12, 2020 8:00 AM - PR NewsWire Bernstein Resumes Abbvie (ABBV) at Outperform November 9, 2020 4:41 PM - StreetInsider Form 4 AbbVie Inc. For: Nov 04 Filed by: SEVERINO MICHAEL November 6, 2020 4:29 PM - SEC Filing Form 4 AbbVie Inc. For: Nov 04 Filed by: SALEKI-GERHARDT AZITA November 6, 2020 4:29 PM - SEC Filing AbbVie to Highlight Blood Cancer Leadership and Advancing Oncology Pipeline at the ASH 62ND Annual Meeting November 5, 2020 9:00 AM - PR NewsWire Form 10-Q AbbVie Inc. For: Sep 30 November 4, 2020 9:54 AM - SEC Filing AbbVie raises profit outlook on Botox recovery signs, new drugs growth October 30, 2020 7:53 AM - StreetInsider Form 8-K AbbVie Inc. For: Oct 30 October 30, 2020 7:53 AM - SEC Filing AbbVie (ABBV) Raises Quarterly Dividend 10.2% to $1.30; 6.4% Yield October 30, 2020 7:49 AM - StreetInsider AbbVie (ABBV) Tops Q3 EPS by 7c, Raises FY Guidance October 30, 2020 7:48 AM - StreetInsider AbbVie Reports Third-Quarter 2020 Financial Results October 30, 2020 7:47 AM - PR NewsWire Options expected to have increasing volume: SBUX ABBV HON TWTR SKX October 30, 2020 4:26 AM - StreetInsider AbbVie (ABBV) calls more active than puts into quarter results and 2021 outlook October 29, 2020 10:03 AM - StreetInsider AbbVie to Present New Analyses from Pivotal Phase 3 Studies for RINVOQ™ (upadacitinib) in Atopic Dermatitis October 29, 2020 2:05 AM - PR NewsWire AbbVie Highlights Innovative Research for People with Rheumatic Diseases with New Data at ACR Convergence 2020 October 28, 2020 8:31 AM - PR NewsWire AbbVie's (ABBV) Allergan Announces Positive Phase 3 Results for AGN-190584 for the Treatment of Presbyopia October 28, 2020 8:30 AM - StreetInsider Allergan, an AbbVie Company, Announces Positive Phase 3 Topline Results for Investigational AGN-190584 for the Treatment of Presbyopia October 28, 2020 8:00 AM - PR NewsWire Truist Securities Starts Abbvie (ABBV) at Buy October 22, 2020 4:10 PM - StreetInsider Abbvie (ABBV) Reiterated Overweight at Morgan Stanley Ahead of Rinvoq vs Dupixent Head to Head Trial Results October 22, 2020 8:10 AM - StreetInsider AbbVie (ABBV) Submits Regulatory Applications to FDA and EMA for RINVOQ in Atopic Dermatitis October 19, 2020 10:08 AM - StreetInsider AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ™ (upadacitinib) in Atopic Dermatitis October 19, 2020 10:06 AM - PR NewsWire Form 8-K AbbVie Inc. For: Oct 19 October 19, 2020 9:14 AM - SEC Filing AbbVie Announces Commencement of Registered Exchange Offers October 19, 2020 8:56 AM - PR NewsWire Form 424B3 AbbVie Inc. October 19, 2020 8:01 AM - SEC Filing Form EFFECT AbbVie Inc. October 19, 2020 6:09 AM - SEC Filing AbbVie (ABBV) Reports VENCLEXTA (venetoclax) Receives FDA Full Approval for Acute Myeloid Leukemia October 19, 2020 5:59 AM - StreetInsider VENCLEXTA® (venetoclax) Receives FDA Full Approval for Acute Myeloid Leukemia (AML) October 16, 2020 7:34 PM - PR NewsWire AbbVie (ABBV) granted regular FDA approval for venetoclax combo - Bloomberg October 16, 2020 1:46 PM - StreetInsider NIH tests therapies to help cut hospital stays for COVID-19 patients October 16, 2020 7:43 AM - StreetInsider Abbvie (ABBV) PT Raised to $120 at JPMorgan October 16, 2020 4:32 AM - StreetInsider J&J raises profit forecast as trial halt weighs October 13, 2020 6:51 AM - StreetInsider Allergan Aesthetics To Present Data From 4 Abstracts At The 2020 American Society For Dermatologic Surgery Virtual Meeting October 9, 2020 9:00 AM - PR NewsWire AbbVie (ABBV) Company, Allergan Aesthetics, Reports Acquisition of Luminera October 7, 2020 8:06 AM - StreetInsider Allergan Aesthetics, an AbbVie Company, Acquires Innovative Luminera Dermal Filler Business October 7, 2020 8:00 AM - PR NewsWire AbbVie to Host Third-Quarter 2020 Earnings Conference Call October 6, 2020 8:00 AM - PR NewsWire Form 4 AbbVie Inc. For: Sep 30 Filed by: RAPP EDWARD J October 2, 2020 4:54 PM - SEC Filing Form 4 AbbVie Inc. For: Sep 30 Filed by: Alpern Robert J October 2, 2020 4:53 PM - SEC Filing Form 4 AbbVie Inc. For: Sep 30 Filed by: LIDDY EDWARD M October 2, 2020 4:53 PM - SEC Filing Form S-4 AbbVie Inc. October 2, 2020 4:37 PM - SEC Filing Form 8-K AbbVie Inc. For: Oct 02 October 2, 2020 4:06 PM - SEC Filing AbbVie to Present New Data From 15 Abstracts at the 2020 Virtual Migraine Trust International Symposium October 2, 2020 8:30 AM - PR NewsWire Ironwood to cut 100 jobs after acid reflux drug fails study September 29, 2020 8:15 AM - StreetInsider Berenberg Starts Abbvie (ABBV) at Hold September 29, 2020 1:20 AM - StreetInsider AbbVie (ABBV) Receives Orphan Drug, Fast Track Designations from FDA for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for Treatment of Spinal Cord Injury September 28, 2020 8:01 AM - StreetInsider AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Co September 28, 2020 8:00 AM - PR NewsWire Malin Akerman Joins CoolSculpting® and CoolTone™ as U.S. Ambassador for the Allergan Aesthetics Body Contouring Portfolio September 16, 2020 8:00 AM - PR NewsWire Allergan Aesthetics and Skinbetter Science Announce The DREAM Initiative™ To Advance Health Equity and Diversity in Aesthetics September 14, 2020 8:00 AM - PR NewsWire AbbVie (ABBV) to Present New Data From 18 Abstracts at the International Congress of Parkinson's Disease and Movement Disorders September 11, 2020 11:32 AM - StreetInsider AbbVie to Present New Data From 18 Abstracts at the International Congress of Parkinson's Disease and Movement Disorders® September 11, 2020 11:30 AM - PR NewsWire AbbVie (ABBV) Declares $1.18 Quarterly Dividend; 5.2% Yield September 11, 2020 9:42 AM - StreetInsider AbbVie Declares Quarterly Dividend September 11, 2020 9:40 AM - PR NewsWire Pre-Open Stock Movers 9/04: (IMAB) (KCAC) (NX) (CVAC) (W) (OSKT) (DOCU) September 4, 2020 8:52 AM - StreetInsider AbbVie (ABBV), I-Mab (IMAB) Enter into Pact for Differentiated Immuno-oncology Therapy September 4, 2020 7:01 AM - StreetInsider AbbVie and I-Mab Enter Into Global Strategic Partnership for Differentiated Immuno-oncology Therapy September 4, 2020 7:00 AM - PR NewsWire AbbVie and I-Mab Enter into Global Strategic Partnership for Differentiated Immuno-oncology Therapy September 4, 2020 7:00 AM - PR NewsWire AbbVie (ABBV) Agrees to $2.9B Cancer Treatment Deal with China's I-Mab (IMAB) - Bloomberg September 4, 2020 6:41 AM - StreetInsider AbbVie to Present at the Morgan Stanley Healthcare Conference September 3, 2020 8:00 AM - PR NewsWire Abbvie (ABBV) PT Raised to $105 at Citi September 2, 2020 5:04 AM - StreetInsider AbbVie (ABBV) Trades at Low, Down 4.4% Following Earlier Report of Subpoena in Drug-Pricing Probe September 1, 2020 11:47 AM - StreetInsider U.S. House Oversight Committee to subpoena AbbVie in drug-pricing probe September 1, 2020 10:28 AM - StreetInsider Full Article List